Peck Wealth Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$20.8K Hold
165
0.02% 121
2026
Q1
$23K Sell
165
-170
-51% -$23.8K 0.02% 118
2025
Q4
$41.1K Hold
335
0.04% 118
2025
Q3
$37.2K Buy
+335
New +$38.1K 0.04% 118

Other funds holding GILD

Peck Wealth Management's GILD Position: Q2 2026 in Review

Peck Wealth Management held its Gilead Sciences (GILD) position steady in Q2 2026 at 165 shares worth $20.8K. The position accounts for 0.02% of the portfolio, ranked #121.

Peck Wealth Management first reported a position in GILD in Q3 2025 and has held it in 4 quarters since. The position peaked at $41.1K in Q4 2025. 2,260 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Peck Wealth Management held 165 shares of Gilead Sciences worth $20.8K as of Q2 2026.
  • Peck Wealth Management left its Gilead Sciences share count unchanged in Q2 2026.
  • Gilead Sciences made up 0.02% of Peck Wealth Management's portfolio in Q2 2026, its #121 holding.
  • Peck Wealth Management first reported a position in Gilead Sciences in Q3 2025 and has held it in 4 quarters since.
  • Peck Wealth Management's Gilead Sciences position peaked at $41.1K in Q4 2025.
  • 2,260 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Peck Wealth Management's 13F filing for Q2 2026, filed 31 Jul 2026.